About

Compared with injectable alternatives, our product CocoNip has three key advantages:

Unique dual-action peptide formula, backed by user insights from long-term use—20% average progress in weight management over 36 weeks, with gentle support for daily routines.

User-reported data reflects an average 20.9% progress in weight management.

Innovative support redefines daily care. It supports balanced appetite and metabolic function through dual-action support, enhancing consistency in progress and delivering practical solutions for sustainable weight management.

Shopping Cart
Scroll to Top